Skip to main content
Premium Trial:

Request an Annual Quote

Cohesive Technologies Wins Patent Suit Against Waters

NEW YORK, Nov. 29 – A Boston jury found that Waters Corporation infringed upon a patent for high throughput liquid chromatography held by Cohesive Technologies, the companies announced Thursday.

The patent, number 5,772,874, is used in Cohesive’s technology in its TurboFlow high throughput liquid chromatography product, according to the company.

“With this lawsuit behind us, we're ready to fast-forward our marketing efforts and pursue strategic relationships with a number of outstanding partners who have been waiting for this suit to be resolved,” Peter Glick, CEO of Franklin, Mass.-based Cohesive, said in a statement. 

Waters said in a statement that the product that used what Cohesive alleged was a patent violation had been removed from its US product line prior to the trial, and that the product “was replaced by a product with better performance.”

Milford, Mass.-based Waters said it would be appealing the court decision.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.